Search

everythinglearnresearchcommunity

for

Search:↓

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

TB and BCC tumors show similar follicular differentiation patterns.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Schwann cell and M2 macrophage interactions contribute to keloid growth by increasing matrix deposition.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

FoxN1 overexpression in young mice harms immune cell and skin development.

Recombinant human TSG-6 speeds up wound healing in diabetic mice.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Patients with certain FoxN1 gene mutations have severe immune issues but normal skin and hair.

Tridax procumbens may boost the immune system.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Finasteride increases CD8+ T cells in BPH tissues.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

Disrupting the Tsc2 gene in certain cells leads to thicker skin, larger hair, and changes in hair growth signaling, which can be partly reversed with specific treatment.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

Biological therapy boosts the immune system to effectively fight melanoma.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Cells that move well may improve hair loss treatments by entering hair follicles.